Breast Cancer Treatment at CritiCare Asia Hospitals, Malad
Breast cancer develops when cells within breast tissue begin dividing abnormally and form a tumour that can grow within the breast or, left unchecked, spread beyond it. It usually starts in the milk ducts or lobules. Around 1 in 28 women in India is at risk during her lifetime. Most cases occur after 50, though younger women are affected too. CritiCare Asia Hospitals, a breast cancer hospital in Mumbai, treats early detection as the strongest advantage a family can have. It is the foundation of breast cancer treatment in Malad, Mumbai.
Symptoms of Breast Cancer
A lump is what most people look for, yet relying on it alone can delay diagnosis. Other signs include:
- A lump or thickened area that feels different from surrounding tissue
- Nipple discharge, particularly if blood-tinged
- Nipple retraction or inversion where there was none before
- Skin dimpling or an orange-peel texture
- Swelling or a new lump in the armpit, even without a breast lump
- Changes in breast size, shape or skin texture
Any persistent change, even a subtle one, deserves evaluation. Reach out to the best oncologists in Mumbai at our hospital for prompt diagnosis and care.
Risk Factors
- BRCA1 and BRCA2 mutations, inherited changes that significantly raise lifetime risk of breast and ovarian cancer
- Early menarche or late menopause, which extends hormone exposure
- Nulliparity, meaning no full-term pregnancy, which carries somewhat higher risk
- Long-term postmenopausal hormone replacement therapy
- Dense breast tissue, which makes mammograms harder to read and is independently linked to higher risk
- Family history, obesity and alcohol use, which contribute less strongly than genetic mutations
Only 5 to 10 percent of breast cancers trace back to an inherited mutation. For most women, it is a mix of factors, which is why regular screening matters regardless of family history.
Types of Breast Cancer
It is a group of conditions that differ in where they start and how they behave.
- Ductal carcinoma in situ (DCIS)
non-invasive, confined to the milk ducts, the earliest form and highly treatable - Invasive ductal carcinoma
the most common type, beginning in the duct lining and spreading into surrounding tissue - Invasive lobular carcinoma
starts in the milk-producing lobules and can be harder to detect on mammography - Triple-negative breast cancer
lacks estrogen, progesterone and HER2 receptors, limiting hormone-based options - HER2-positive breast cancer
driven by excess HER2 protein and responsive to HER2-targeted therapy - Inflammatory breast cancer
rare and fast-moving, causing redness and swelling rather than a lump, often mistaken for infection early on
Our oncologists and breast cancer surgeons in Malad, Mumbai explain the type and what it means to the patient and family.
Screening for Breast Cancer
- Clinical breast exam of both breasts and the armpit lymph nodes
- Mammography, the primary screening tool; the starting age is best discussed with a doctor based on personal risk
- Breast self-exam, since knowing your own normal helps catch changes between screenings
- MRI for women at high genetic or familial risk, used alongside mammography
Diagnosis of Breast Cancer
A core needle biopsy gives tissue for a definitive diagnosis. The sample is analysed for cell type, grade and receptor status (estrogen, progesterone and HER2), because these results shape which treatments will be effective. Women with a strong family history are usually offered genetic counselling to decide whether BRCA or other hereditary testing makes sense for them and their relatives.
Our Treatment Approach
Decisions rest on type, stage, grade and receptor status, and most women receive more than one form of treatment.
- Breast-conserving surgery, removing the tumour with a margin of healthy tissue
- Mastectomy, removing all breast tissue, sometimes extended to the opposite breast for high genetic risk
- Sentinel lymph node biopsy, to check for spread to nearby nodes and often avoid wider removal
- Radiation therapy, commonly after breast-conserving surgery to reduce recurrence
- Chemotherapy, before or after surgery depending on type and stage
- Hormone therapy for estrogen or progesterone receptor-driven cancers
- Targeted therapy (trastuzumab) for HER2-positive cancers
- Reconstruction after mastectomy, at the time of surgery or afterwards
Families can ask our team about breast cancer surgery in Malad, Mumbai.
Breast Cancer Treatment at CritiCare Asia Hospitals, Malad
Breast cancer care runs across months of surgery, therapy and follow-up, and the family walks through it too. CritiCare Asia Hospitals, a leading breast cancer hospital in Malad, Mumbai, is committed to providing advanced breast cancer care. Care starts with a complete diagnostic picture of biopsy, receptor testing, and imaging. Our doctors then weigh breast-conserving surgery against mastectomy with the patient, sequence chemotherapy, radiation or hormone therapy by stage, and discuss reconstruction during surgical planning. If you have noticed a lump, skin change or nipple discharge, speak with our oncology team for prompt evaluation.